IBDEI08W ; ; 12-JAN-2012
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JAN 12, 2012
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11914,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11914,1,4,0)
 ;;=4^V19.0
 ;;^UTILITY(U,$J,358.3,11914,1,5,0)
 ;;=5^Family h/o Blindness
 ;;^UTILITY(U,$J,358.3,11914,2)
 ;;=^295320
 ;;^UTILITY(U,$J,358.3,11915,0)
 ;;=V16.3^^88^704^7
 ;;^UTILITY(U,$J,358.3,11915,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11915,1,4,0)
 ;;=4^V16.3
 ;;^UTILITY(U,$J,358.3,11915,1,5,0)
 ;;=5^Family h/o Cancer of Breast
 ;;^UTILITY(U,$J,358.3,11915,2)
 ;;=^295295
 ;;^UTILITY(U,$J,358.3,11916,0)
 ;;=V16.41^^88^704^10
 ;;^UTILITY(U,$J,358.3,11916,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11916,1,4,0)
 ;;=4^V16.41
 ;;^UTILITY(U,$J,358.3,11916,1,5,0)
 ;;=5^Family h/o Cancer of Ovary
 ;;^UTILITY(U,$J,358.3,11916,2)
 ;;=^317951
 ;;^UTILITY(U,$J,358.3,11917,0)
 ;;=V16.42^^88^704^11
 ;;^UTILITY(U,$J,358.3,11917,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11917,1,4,0)
 ;;=4^V16.42
 ;;^UTILITY(U,$J,358.3,11917,1,5,0)
 ;;=5^Family h/o Cancer of Prostate
 ;;^UTILITY(U,$J,358.3,11917,2)
 ;;=^317952
 ;;^UTILITY(U,$J,358.3,11918,0)
 ;;=V16.43^^88^704^12
 ;;^UTILITY(U,$J,358.3,11918,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11918,1,4,0)
 ;;=4^V16.43
 ;;^UTILITY(U,$J,358.3,11918,1,5,0)
 ;;=5^Family h/o Cancer of Testis
 ;;^UTILITY(U,$J,358.3,11918,2)
 ;;=^317953
 ;;^UTILITY(U,$J,358.3,11919,0)
 ;;=V19.5^^88^704^13
 ;;^UTILITY(U,$J,358.3,11919,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11919,1,4,0)
 ;;=4^V19.5
 ;;^UTILITY(U,$J,358.3,11919,1,5,0)
 ;;=5^Family h/o Congenital Anomalies
 ;;^UTILITY(U,$J,358.3,11919,2)
 ;;=^295325
 ;;^UTILITY(U,$J,358.3,11920,0)
 ;;=V19.2^^88^704^14
 ;;^UTILITY(U,$J,358.3,11920,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11920,1,4,0)
 ;;=4^V19.2
 ;;^UTILITY(U,$J,358.3,11920,1,5,0)
 ;;=5^Family h/o Deafness Or Hearing Loss
 ;;^UTILITY(U,$J,358.3,11920,2)
 ;;=^295322
 ;;^UTILITY(U,$J,358.3,11921,0)
 ;;=V17.3^^88^704^16
 ;;^UTILITY(U,$J,358.3,11921,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11921,1,4,0)
 ;;=4^V17.3
 ;;^UTILITY(U,$J,358.3,11921,1,5,0)
 ;;=5^Family h/o Ischemic Heart Dis
 ;;^UTILITY(U,$J,358.3,11921,2)
 ;;=^295305
 ;;^UTILITY(U,$J,358.3,11922,0)
 ;;=V16.6^^88^704^17
 ;;^UTILITY(U,$J,358.3,11922,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11922,1,4,0)
 ;;=4^V16.6
 ;;^UTILITY(U,$J,358.3,11922,1,5,0)
 ;;=5^Family h/o Leukemia
 ;;^UTILITY(U,$J,358.3,11922,2)
 ;;=^295298
 ;;^UTILITY(U,$J,358.3,11923,0)
 ;;=V18.61^^88^704^19
 ;;^UTILITY(U,$J,358.3,11923,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11923,1,4,0)
 ;;=4^V18.61
 ;;^UTILITY(U,$J,358.3,11923,1,5,0)
 ;;=5^Family h/o Polycystic Kidney
 ;;^UTILITY(U,$J,358.3,11923,2)
 ;;=^321531
 ;;^UTILITY(U,$J,358.3,11924,0)
 ;;=V17.0^^88^704^20
 ;;^UTILITY(U,$J,358.3,11924,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11924,1,4,0)
 ;;=4^V17.0
 ;;^UTILITY(U,$J,358.3,11924,1,5,0)
 ;;=5^Family h/o Psychiatric Condition
 ;;^UTILITY(U,$J,358.3,11924,2)
 ;;=^295302
 ;;^UTILITY(U,$J,358.3,11925,0)
 ;;=V19.4^^88^704^21
 ;;^UTILITY(U,$J,358.3,11925,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11925,1,4,0)
 ;;=4^V19.4
 ;;^UTILITY(U,$J,358.3,11925,1,5,0)
 ;;=5^Family h/o Skin Condition
 ;;^UTILITY(U,$J,358.3,11925,2)
 ;;=^295324
 ;;^UTILITY(U,$J,358.3,11926,0)
 ;;=V17.1^^88^704^22
 ;;^UTILITY(U,$J,358.3,11926,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11926,1,4,0)
 ;;=4^V17.1
 ;;^UTILITY(U,$J,358.3,11926,1,5,0)
 ;;=5^Family h/o Stroke (Cerebrovascular)
 ;;^UTILITY(U,$J,358.3,11926,2)
 ;;=^295303
 ;;^UTILITY(U,$J,358.3,11927,0)
 ;;=V16.8^^88^704^18
 ;;^UTILITY(U,$J,358.3,11927,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11927,1,4,0)
 ;;=4^V16.8
 ;;^UTILITY(U,$J,358.3,11927,1,5,0)
 ;;=5^Family h/o Other Specified Cancer
 ;;^UTILITY(U,$J,358.3,11927,2)
 ;;=^295300
 ;;^UTILITY(U,$J,358.3,11928,0)
 ;;=V11.1^^88^704^41
 ;;^UTILITY(U,$J,358.3,11928,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11928,1,4,0)
 ;;=4^V11.1
 ;;^UTILITY(U,$J,358.3,11928,1,5,0)
 ;;=5^Personal h/o Affective Disorder
 ;;^UTILITY(U,$J,358.3,11928,2)
 ;;=^295250
 ;;^UTILITY(U,$J,358.3,11929,0)
 ;;=V15.89^^88^704^49
 ;;^UTILITY(U,$J,358.3,11929,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11929,1,4,0)
 ;;=4^V15.89
 ;;^UTILITY(U,$J,358.3,11929,1,5,0)
 ;;=5^Personal h/o Exposure To Persian Gulf Region
 ;;^UTILITY(U,$J,358.3,11929,2)
 ;;=^295291
 ;;^UTILITY(U,$J,358.3,11930,0)
 ;;=V11.3^^88^704^42
 ;;^UTILITY(U,$J,358.3,11930,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11930,1,4,0)
 ;;=4^V11.3
 ;;^UTILITY(U,$J,358.3,11930,1,5,0)
 ;;=5^Personal h/o Alcoholism
 ;;^UTILITY(U,$J,358.3,11930,2)
 ;;=^295252
 ;;^UTILITY(U,$J,358.3,11931,0)
 ;;=V15.07^^88^704^43
 ;;^UTILITY(U,$J,358.3,11931,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11931,1,4,0)
 ;;=4^V15.07
 ;;^UTILITY(U,$J,358.3,11931,1,5,0)
 ;;=5^Personal h/o Allerlgy to Latex
 ;;^UTILITY(U,$J,358.3,11931,2)
 ;;=^322043
 ;;^UTILITY(U,$J,358.3,11932,0)
 ;;=V13.4^^88^704^44
 ;;^UTILITY(U,$J,358.3,11932,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11932,1,4,0)
 ;;=4^V13.4
 ;;^UTILITY(U,$J,358.3,11932,1,5,0)
 ;;=5^Personal h/o Arthritis
 ;;^UTILITY(U,$J,358.3,11932,2)
 ;;=^295267
 ;;^UTILITY(U,$J,358.3,11933,0)
 ;;=V12.72^^88^704^45
 ;;^UTILITY(U,$J,358.3,11933,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11933,1,4,0)
 ;;=4^V12.72
 ;;^UTILITY(U,$J,358.3,11933,1,5,0)
 ;;=5^Personal h/o Colon Polyps
 ;;^UTILITY(U,$J,358.3,11933,2)
 ;;=^303401
 ;;^UTILITY(U,$J,358.3,11934,0)
 ;;=V12.59^^88^704^46
 ;;^UTILITY(U,$J,358.3,11934,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11934,1,4,0)
 ;;=4^V12.59
 ;;^UTILITY(U,$J,358.3,11934,1,5,0)
 ;;=5^Personal h/o Congestive Heart Failure
 ;;^UTILITY(U,$J,358.3,11934,2)
 ;;=^303399
 ;;^UTILITY(U,$J,358.3,11935,0)
 ;;=V45.81^^88^704^47
 ;;^UTILITY(U,$J,358.3,11935,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11935,1,4,0)
 ;;=4^V45.81
 ;;^UTILITY(U,$J,358.3,11935,1,5,0)
 ;;=5^Personal h/o Coronary Bypass
 ;;^UTILITY(U,$J,358.3,11935,2)
 ;;=^97129
 ;;^UTILITY(U,$J,358.3,11936,0)
 ;;=V15.84^^88^704^48
 ;;^UTILITY(U,$J,358.3,11936,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11936,1,4,0)
 ;;=4^V15.84
 ;;^UTILITY(U,$J,358.3,11936,1,5,0)
 ;;=5^Personal h/o Exposure To Asbestos
 ;;^UTILITY(U,$J,358.3,11936,2)
 ;;=^303406
 ;;^UTILITY(U,$J,358.3,11937,0)
 ;;=V15.85^^88^704^53
 ;;^UTILITY(U,$J,358.3,11937,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11937,1,4,0)
 ;;=4^V15.85
 ;;^UTILITY(U,$J,358.3,11937,1,5,0)
 ;;=5^Personal h/o Potentially Hazardous Body Fluids
 ;;^UTILITY(U,$J,358.3,11937,2)
 ;;=^303407
 ;;^UTILITY(U,$J,358.3,11938,0)
 ;;=V10.72^^88^704^51
 ;;^UTILITY(U,$J,358.3,11938,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11938,1,4,0)
 ;;=4^V10.72
 ;;^UTILITY(U,$J,358.3,11938,1,5,0)
 ;;=5^Personal h/o Hodgkin's Disease
 ;;^UTILITY(U,$J,358.3,11938,2)
 ;;=^295237
 ;;^UTILITY(U,$J,358.3,11939,0)
 ;;=V15.3^^88^704^52
 ;;^UTILITY(U,$J,358.3,11939,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11939,1,4,0)
 ;;=4^V15.3
 ;;^UTILITY(U,$J,358.3,11939,1,5,0)
 ;;=5^Personal h/o Irradiation
 ;;^UTILITY(U,$J,358.3,11939,2)
 ;;=^295285
 ;;^UTILITY(U,$J,358.3,11940,0)
 ;;=V10.61^^88^704^26
 ;;^UTILITY(U,$J,358.3,11940,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11940,1,4,0)
 ;;=4^V10.61
 ;;^UTILITY(U,$J,358.3,11940,1,5,0)
 ;;=5^Hx of Lymphoid Leukemia
 ;;^UTILITY(U,$J,358.3,11940,2)
 ;;=Hx of Lymphoid Leukemia^295232
 ;;^UTILITY(U,$J,358.3,11941,0)
 ;;=V12.03^^88^704^27
 ;;^UTILITY(U,$J,358.3,11941,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11941,1,4,0)
 ;;=4^V12.03
 ;;^UTILITY(U,$J,358.3,11941,1,5,0)
 ;;=5^Hx of Malaria
 ;;^UTILITY(U,$J,358.3,11941,2)
 ;;=Hx of Malaria^303395
 ;;^UTILITY(U,$J,358.3,11942,0)
 ;;=V10.82^^88^704^28
 ;;^UTILITY(U,$J,358.3,11942,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11942,1,4,0)
 ;;=4^V10.82
 ;;^UTILITY(U,$J,358.3,11942,1,5,0)
 ;;=5^Hx of Malignant Melanoma
 ;;^UTILITY(U,$J,358.3,11942,2)
 ;;=Hx of Malignant Melanoma^295240
 ;;^UTILITY(U,$J,358.3,11943,0)
 ;;=V10.62^^88^704^30
 ;;^UTILITY(U,$J,358.3,11943,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11943,1,4,0)
 ;;=4^V10.62
 ;;^UTILITY(U,$J,358.3,11943,1,5,0)
 ;;=5^Hx of Myeloid Leukemia
 ;;^UTILITY(U,$J,358.3,11943,2)
 ;;=Hx of Myeloid Leukemia^295233
 ;;^UTILITY(U,$J,358.3,11944,0)
 ;;=V10.63^^88^704^29
 ;;^UTILITY(U,$J,358.3,11944,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11944,1,4,0)
 ;;=4^V10.63
 ;;^UTILITY(U,$J,358.3,11944,1,5,0)
 ;;=5^Hx of Monocytic Leukemia
 ;;^UTILITY(U,$J,358.3,11944,2)
 ;;=Hx of Monocytic Leukemia^295234
 ;;^UTILITY(U,$J,358.3,11945,0)
 ;;=V11.2^^88^704^24
 ;;^UTILITY(U,$J,358.3,11945,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11945,1,4,0)
 ;;=4^V11.2
 ;;^UTILITY(U,$J,358.3,11945,1,5,0)
 ;;=5^Hx of Dysthymia
 ;;^UTILITY(U,$J,358.3,11945,2)
 ;;=Hx of Dysthymia^295251
 ;;^UTILITY(U,$J,358.3,11946,0)
 ;;=V15.81^^88^704^40
 ;;^UTILITY(U,$J,358.3,11946,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11946,1,4,0)
 ;;=4^V15.81
 ;;^UTILITY(U,$J,358.3,11946,1,5,0)
 ;;=5^Noncompliance With Medical Treatment
 ;;^UTILITY(U,$J,358.3,11946,2)
 ;;=^295290
 ;;^UTILITY(U,$J,358.3,11947,0)
 ;;=V10.43^^88^704^31
 ;;^UTILITY(U,$J,358.3,11947,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11947,1,4,0)
 ;;=4^V10.43
 ;;^UTILITY(U,$J,358.3,11947,1,5,0)
 ;;=5^Hx of Ovarian CA
 ;;^UTILITY(U,$J,358.3,11947,2)
 ;;=Hx of Ovarian CA^295221
 ;;^UTILITY(U,$J,358.3,11948,0)
 ;;=V12.71^^88^704^32
 ;;^UTILITY(U,$J,358.3,11948,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11948,1,4,0)
 ;;=4^V12.71
 ;;^UTILITY(U,$J,358.3,11948,1,5,0)
 ;;=5^Hx of Peptic Ulcer Disease
 ;;^UTILITY(U,$J,358.3,11948,2)
 ;;=^303400
 ;;^UTILITY(U,$J,358.3,11949,0)
 ;;=V10.46^^88^704^33
 ;;^UTILITY(U,$J,358.3,11949,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11949,1,4,0)
 ;;=4^V10.46
 ;;^UTILITY(U,$J,358.3,11949,1,5,0)
 ;;=5^Hx of Prostate Cancer
 ;;^UTILITY(U,$J,358.3,11949,2)
 ;;=Hx of Prostate Cancer^295224
 ;;^UTILITY(U,$J,358.3,11950,0)
 ;;=V11.0^^88^704^34
